“…Only Patel and co-workers reported that the compounds bearing the 4 H -benzo[4,5]-thiazolo[3,2- a ]pyrimidine moiety could be used as antimycobacterial and antioxidant agents (Figure ). The existing synthetic methods for this kind of compound only include (i) the synthesis of 3-substituted 2-hydroxy-4 H -benzo[4,5]-thiazolo[3,2- a ]pyrimidine-4-ones by the reactions of substituted malonic esters and 6-methoxy-1,3-benzothiazolyl-2-amine at 200 °C, (ii) the microwave-assisted synthesis of ethyl 2-methyl-4-(pyridin-2-yl)-4 H -benzo[4,5]thiazolo[3,2- a ]pyrimidine-3-carboxylates by the reactions of 2-aminobenzothiazoles with pyridine-2-aldehyde and ethyl acetoacetate in the presence of PdCl 2 as an expeditious catalyst, , and (iii) the synthesis of 2,4-diaryl-6,7,8,9-tetrahydro-4 H -benzo[4,5]thiazolo[3,2- a ]pyrimidine hydrobromides by the α-bromination of cyclohexanone with N -bromosuccinamide (NBS), followed by cyclization with 3,4-dihydropyrimidine-2(1 H )-thiones in the presence of p -toluenesulfonic acid (PTSA) (Scheme ). However, some drawbacks still remain for these methods, such as the use of a very high temperature, the use of noble transition metal as a catalyst, the limited product examples, etc.…”